tiprankstipranks
Outlook Therapeutics (OTLK)
NASDAQ:OTLK
Holding OTLK?
Track your performance easily

Outlook Therapeutics (OTLK) Income Statement

1,296 Followers

Outlook Therapeutics Income Statement

Last quarter (Q3 2024), Outlook Therapeutics's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Outlook Therapeutics's net income was $44.41M. See Outlook Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Sep 23Sep 22Sep 21Sep 20Sep 19
Total Revenue
-----$ 8.15M
Cost of Revenue
------
Gross Profit
-----$ 8.15M
Operating Expense
$ 61.28M$ 53.13M$ 63.07M$ 51.73M$ 36.84M$ -44.45M
Operating Income
$ -61.28M$ -53.13M$ -63.07M$ -51.73M$ -36.84M$ -25.65M
Net Non Operating Interest Income Expense
$ -2.18M$ -1.56M$ -1.49M$ -936.13K$ -1.76M$ -3.47M
Other Income Expense
$ -9.71M$ 537.74K$ -1.49M$ 498.49K$ 1.88M$ -1.83M
Pretax Income
$ -93.05M$ -58.98M$ -66.05M$ -53.16M$ -38.51M$ -37.93M
Tax Provision
$ 2.80K$ 2.80K$ 2.80K$ 2.00K$ -3.27M$ -3.41M
Earnings From Equity Interest Net Of Tax
$ -93.89K$ -11.00K$ -48.73K$ -46.34K--
Net Income Common Stockholders
$ -94.05M$ -58.98M$ -66.05M$ -53.16M$ -48.87M$ -36.04M
Basic EPS
$ -6.95$ -0.24$ -6.20$ -7.00$ -13.40-
Diluted EPS
$ -9.75$ -0.24$ -6.20$ -7.00$ -13.40$ -1.98
Basic Average Shares
$ 310.26M$ 250.18M$ 10.60M$ 7.63M$ 3.63M$ 18.19M
Diluted Average Shares
$ 312.51M$ 250.18M$ 10.60M$ 7.63M$ 3.63M$ 17.77M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 61.28M$ 53.13M$ 63.07M$ 51.73M$ 36.84M$ -44.45M
Net Income From Continuing And Discontinued Operation
$ -94.05M$ -58.98M$ -66.05M$ -53.16M$ -35.24M$ -35.15M
Normalized Income
$ -89.52M$ -46.59M-$ -42.00M--
Interest Expense
------
EBIT
$ -47.80M$ -57.42M$ -64.56M$ -52.23M$ -36.75M$ -37.26M
EBITDA
$ -47.73M$ -57.38M$ -64.36M$ -51.96M$ -36.20M$ -33.90M
Currency in USD

Outlook Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis